ZSY-32758-78128 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-11
Dose 1 — Janssen/Johnson & Johnson
2021-12-31
Dose 2 — Moderna
2022-01-02
Registered in v-safe
2022-01-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2022-01-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2022-01-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2022-01-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2022-01-06
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · None

Adult check-in
2022-01-09
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2022-01-14
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2022-01-21
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2022-01-30
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2022-02-04
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2022-02-11
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2022-04-01
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2022-07-01
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-12-31
Survey response — 12 months, dose 2
MedDRA: COVID-19, Pulmonary embolism — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Micro Pulmonary embolisms. And Covid.

MedDRA releases: 2024-11 · check-in free text available
2022-12-31
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2023-01-03
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-11	Janssen/Johnson & Johnson	No
2	2021-12-31	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2022-12-31	Successful 2023-01-03	Participant prefers to complete VAERS report online

Free text

Release 12 — 12 months, dose 2

2022-12-31

Symptoms: Micro Pulmonary embolisms. And Covid.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Pulmonary embolism	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release